Cementless total knee arthroplasty Market By Product (Mobile Bearings, Fixed Bearings), By Material (Ceramics, Alloy, Others), By End User (Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Cementless total knee arthroplasty Market

Cementless implants have shown to reduce the prevalence of radiological radiolucent lines (RLL), which may help to improve implant survivorship and reduce revision rates compared to cemented implants for uni-compartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA). These advantages have led to a number of high-volume centers selecting cementless over cemented UKA, with excellent patient-reported outcomes and implant survivorship of over 97% at minimum ten years follow-up.               

Key factors driving the growth of the cementless total knee arthroplasty market include rise in prevalence of knee osteoarthritis, technological advancements in cementless knee implants and rise in number of sports related injuries and road-accidents.  

People are becoming more conscious about maintaining an active and healthy lifestyle, even as they age. Cementless knee arthroplasty allows individuals to regain knee function and engage in activities such as sports, exercise, and recreational pursuits. The desire to maintain an active lifestyle fuels the demand for knee arthroplasty procedures, driving market growth.  

In addition, surge in prevalence of knee osteoarthritis and rheumatoid arthritis and increase in the number of procedures of total knee replacement are the major factors that increases the demand for cementless total knee arthroplasty implants and hence propel the growth of the market. For instance, according to a report published by Osteoarthritis Foundation International in 2021, worldwide, an estimated 500 million people have osteoarthritis, whereas more than 32.5 million U.S. adults have osteoarthritis out of which 62% of people with osteoarthritis are women and more than 22% of adults around the world who are older than 40 have knee osteoarthritis. In Spain the figure is of 7 million patients. In addition, it is the main cause of permanent disability and the third cause of temporary working place disability.   

Furthermore, the rise in obesity rates is a substantial risk factor for conditions affecting the knee joints, such as osteoarthritis. The number of people needing knee replacement surgery is rising along with the global incidence of obesity. For instance, according to a research released by the International Diabetes Federation in 2021, roughly 537 million individuals (20-79 years) currently have diabetes. However, by 2030 and 2045, it is anticipated that this number would increase to 643 million and 783 million, respectively. In light of its enhanced stability and long-term durability, cementless knee arthroplasty offers an effective treatment for obese patients and is anticipated to drive the market's expansion.

Moreover, advancements in technologies, such as continuous development of advanced implant designs, materials, and surgical techniques have significantly improved the outcomes of cementless knee arthroplasty. These advancements offer benefits such as improved longevity, better range of motion, reduced complications, and faster recovery. Technological innovations attract both patients and surgeons, thereby driving the market growth. For instance, in November 2022, Zimmer Biomet Holdings, Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement. Persona OsseoTi is the latest addition to the clinically proven Persona knee system and features a new porous version of the Persona anatomic tibia with Zimmer Biomet's OsseoTi Porous Metal Technology.   

In addition, the introduction of minimally invasive surgical approaches has facilitated shorter hospital stays, reduced complications, and faster rehabilitation, making cementless knee arthroplasty more appealing to patients and surgeons. Thus, all these factors collectively are anticipated to boost the growth of the market.  

The market also offers growth opportunities to the key players in the market. Cementless knee arthroplasty offers certain advantages over the traditional cemented approach. These advantages include better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries. Surgeons and patients are increasingly recognizing these benefits, leading to a shift toward cementless knee arthroplasty, which is expected to provide lucrative opportunities for market growth.   

Furthermore, increased awareness campaigns about knee joint diseases, treatment options, and the benefits of cementless knee arthroplasty can encourage patients to seek appropriate medical interventions. Patient education initiatives can help individuals make informed decisions about their healthcare, leading to increased demand for cementless knee arthroplasty. Thus, this accelerating change offers an opportunity for key market players to invest in cementless total knee arthroplasty devices, which boosts the growth of the market. All these factors, collectively, are expected to open new avenues for the growth of the cementless total knee arthroplasty during the forecast period. 

The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).             

The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV.  

Key Market Insights 

By product, the fixed bearings segment is expected to experience rapid growth in the market and is estimated to reach $2,522.66 million by 2032, with a CAGR of 4.8%. However, the mobile bearings segment is estimated to be growing with a significant CAGR of 3.7% during the forecast period. 

By material, the alloy segment dominated the global market. However, the others segment is expected to grow with a significant CAGR of 4.6% during the forecast period. 

By end user, the hospitals segment dominated the global market. However, the others segment is expected to grow with a fastest CAGR of 5.5% during the forecast period. 

Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 5.5% during the forecast period. 

 

Overview

The cementless total knee arthroplasty Market was valued for $1,938.81 million in 2022 and is estimated to reach $3,032.56 million by 2032, exhibiting a CAGR of 4.6% from 2023 to 2032. Cementless knee implants, also known as press-fit knee implants, have a rough, porous surface that encourages new bone growth. The new bone grows into the spaces in the implant, holding it in place without the need for cement. The bones within the knee are shaped with special tools so that they fit snugly with the implant. In some cases, screws may be used to hold the prosthetics in place while the bone grows. Currently, cementless implants are only available for total knee replacements.  

Major factors that drive the growth of the global cementless total knee arthroplasty market include increase in prevalence of rheumatoid arthritis and sports-related injuries, technological advancement in implant designs, materials, and surgical techniques that has significantly improved the outcomes of cementless knee arthroplasty. For instance, according to the report published by Global RA Network, in 2021, it has been reported that more than 350 million people have arthritis globally in which up to 3% of the global population has psoriatic arthritis and 14 million people have rheumatoid arthritis.,   

Furthermore, the surge in the number of R&D activities for the development of technologically advanced medical devices used in knee arthroplasty and rapidly growing geriatric population are the factors that propel the growth of the market. In addition, the advantage of cementless knee arthroplasty over cemented implants such as better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries leading to a shift toward cementless knee arthroplasty that increases the adoption of the cementless total knee arthroplasty platforms, thus propelling the market growth.   

However, the high cost associated with cementless knee arthroplasty implants and easy availability of alternatives such as cemented knee arthroplasty are the major barriers to the growth of the market. On the contrary, growing patients' preference for cementless implants and favorable reimbursement policies and insurance coverage for cementless knee arthroplasty procedures are expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.   

The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).   

The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV. The major players in the market have adopted product launch and innovation as key developmental strategies to improve the product portfolio of the cementless total knee arthroplasty market.  

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cementless total knee arthroplasty market analysis from 2022 to 2032 to identify the prevailing cementless total knee arthroplasty market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the cementless total knee arthroplasty market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global cementless total knee arthroplasty market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

○ Zimmer Biomet Holding Inc

Scope of Cementless total knee arthroplasty Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Low threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of knee osteoarthritis

3.4.1.2. Technological advancements in knee arthroplasty implants

3.4.1.3. Rise in the number of sports related injuries

3.4.2. Restraints

3.4.2.1. High cost of cementless knee arthroplasty implants

3.4.3. Opportunities

3.4.3.1. Rise in popularity of cementless total knee arthroplasty over cemented knee arthroplasty

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Mobile Bearings

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Fixed Bearings

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Ceramics

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Alloy

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Others

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Product

7.2.3. Market size and forecast, by Material

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Product

7.2.5.1.3. Market size and forecast, by Material

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Product

7.2.5.2.3. Market size and forecast, by Material

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Product

7.2.5.3.3. Market size and forecast, by Material

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Product

7.3.3. Market size and forecast, by Material

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Product

7.3.5.1.3. Market size and forecast, by Material

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Product

7.3.5.2.3. Market size and forecast, by Material

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Product

7.3.5.3.3. Market size and forecast, by Material

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Product

7.3.5.4.3. Market size and forecast, by Material

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Product

7.3.5.5.3. Market size and forecast, by Material

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Product

7.3.5.6.3. Market size and forecast, by Material

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Product

7.4.3. Market size and forecast, by Material

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Product

7.4.5.1.3. Market size and forecast, by Material

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Product

7.4.5.2.3. Market size and forecast, by Material

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. Australia

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Product

7.4.5.3.3. Market size and forecast, by Material

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. India

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Product

7.4.5.4.3. Market size and forecast, by Material

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Product

7.4.5.5.3. Market size and forecast, by Material

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Product

7.4.5.6.3. Market size and forecast, by Material

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Product

7.5.3. Market size and forecast, by Material

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Product

7.5.5.1.3. Market size and forecast, by Material

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Product

7.5.5.2.3. Market size and forecast, by Material

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Product

7.5.5.3.3. Market size and forecast, by Material

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Product

7.5.5.4.3. Market size and forecast, by Material

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2022

9.1. Zimmer Biomet Holding Inc.

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.1.7. Key strategic moves and developments

9.2. Stryker Corporation.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. Johnson & Johnson

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.3.7. Key strategic moves and developments

9.4. B. Braun Melsungen AG

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.4.6. Business performance

9.5. MicroPort Scientific Corporation

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.5.6. Business performance

9.6. Waldemar Link GmbH & Co. KG

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.7. United Orthopedic Corporation

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. X. NOV

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Key strategic moves and developments

9.9. Smith & Nephew plc

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.9.7. Key strategic moves and developments

9.10. Olympus Corporation

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 02. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR MOBILE BEARINGS, BY REGION, 2022-2032 ($MILLION)

TABLE 03. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR FIXED BEARINGS, BY REGION, 2022-2032 ($MILLION)

TABLE 04. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 05. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR CERAMICS, BY REGION, 2022-2032 ($MILLION)

TABLE 06. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR ALLOY, BY REGION, 2022-2032 ($MILLION)

TABLE 07. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 08. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 09. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)

TABLE 10. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 11. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 12. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 13. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 14. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 15. NORTH AMERICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 16. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 17. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 18. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 19. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 20. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 21. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 22. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 23. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 24. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 25. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 26. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 27. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 28. EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 29. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 30. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 31. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 32. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 33. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 34. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 35. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 36. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 37. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 38. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 39. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 40. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 41. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 42. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 43. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 44. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 45. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 46. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 47. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 48. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 49. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 50. ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 51. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 52. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 53. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 54. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 55. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 56. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 57. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 58. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 59. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 60. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 61. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 62. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 63. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 64. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 65. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 66. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 67. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 68. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 69. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 70. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 71. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 72. LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 73. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 74. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 75. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 76. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 77. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 78. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 79. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 80. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 81. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 82. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022-2032 ($MILLION)

TABLE 83. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022-2032 ($MILLION)

TABLE 84. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 85. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES

TABLE 86. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT

TABLE 87. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS

TABLE 88. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO

TABLE 89. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES

TABLE 90. STRYKER CORPORATION.: KEY EXECUTIVES

TABLE 91. STRYKER CORPORATION.: COMPANY SNAPSHOT

TABLE 92. STRYKER CORPORATION.: PRODUCT SEGMENTS

TABLE 93. STRYKER CORPORATION.: PRODUCT PORTFOLIO

TABLE 94. JOHNSON & JOHNSON: KEY EXECUTIVES

TABLE 95. JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 96. JOHNSON & JOHNSON: PRODUCT SEGMENTS

TABLE 97. JOHNSON & JOHNSON: PRODUCT PORTFOLIO

TABLE 98. JOHNSON & JOHNSON: KEY STRATERGIES

TABLE 99. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES

TABLE 100. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 101. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS

TABLE 102. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 103. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES

TABLE 104. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 105. MICROPORT SCIENTIFIC CORPORATION: PRODUCT SEGMENTS

TABLE 106. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 107. WALDEMAR LINK GMBH & CO. KG: KEY EXECUTIVES

TABLE 108. WALDEMAR LINK GMBH & CO. KG: COMPANY SNAPSHOT

TABLE 109. WALDEMAR LINK GMBH & CO. KG: SERVICE SEGMENTS

TABLE 110. WALDEMAR LINK GMBH & CO. KG: PRODUCT PORTFOLIO

TABLE 111. UNITED ORTHOPEDIC CORPORATION: KEY EXECUTIVES

TABLE 112. UNITED ORTHOPEDIC CORPORATION: COMPANY SNAPSHOT

TABLE 113. UNITED ORTHOPEDIC CORPORATION: PRODUCT SEGMENTS

TABLE 114. UNITED ORTHOPEDIC CORPORATION: SERVICE SEGMENTS

TABLE 115. UNITED ORTHOPEDIC CORPORATION: PRODUCT PORTFOLIO

TABLE 116. X. NOV: KEY EXECUTIVES

TABLE 117. X. NOV: COMPANY SNAPSHOT

TABLE 118. X. NOV: PRODUCT SEGMENTS

TABLE 119. X. NOV: SERVICE SEGMENTS

TABLE 120. X. NOV: PRODUCT PORTFOLIO

TABLE 121. X. NOV: KEY STRATERGIES

TABLE 122. SMITH & NEPHEW PLC: KEY EXECUTIVES

TABLE 123. SMITH & NEPHEW PLC: COMPANY SNAPSHOT

TABLE 124. SMITH & NEPHEW PLC: PRODUCT SEGMENTS

TABLE 125. SMITH & NEPHEW PLC: PRODUCT PORTFOLIO

TABLE 126. SMITH & NEPHEW PLC: KEY STRATERGIES

TABLE 127. OLYMPUS CORPORATION: KEY EXECUTIVES

TABLE 128. OLYMPUS CORPORATION: COMPANY SNAPSHOT

TABLE 129. OLYMPUS CORPORATION: PRODUCT SEGMENTS

TABLE 130. OLYMPUS CORPORATION: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032

FIGURE 03. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET,2022-2032

FIGURE 04. TOP INVESTMENT POCKETS IN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET (2023-2032)

FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 06. LOW THREAT OF NEW ENTRANTS

FIGURE 07. LOW THREAT OF SUBSTITUTES

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. LOW BARGAINING POWER OF BUYERS

FIGURE 10. GLOBAL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY PRODUCT, 2022(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR MOBILE BEARINGS, BY COUNTRY 2022-2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR FIXED BEARINGS, BY COUNTRY 2022-2032(%)

FIGURE 14. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY MATERIAL, 2022(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR CERAMICS, BY COUNTRY 2022-2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR ALLOY, BY COUNTRY 2022-2032(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)

FIGURE 18. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, BY END USER, 2022(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR HOSPITALS, BY COUNTRY 2022-2032(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)

FIGURE 21. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET BY REGION, 2022

FIGURE 22. U.S. CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 23. CANADA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 24. MEXICO CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 25. GERMANY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 26. FRANCE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 27. UK CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 28. ITALY CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 29. SPAIN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 30. REST OF EUROPE CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 31. JAPAN CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 32. CHINA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 33. AUSTRALIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 34. INDIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 35. SOUTH KOREA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 36. REST OF ASIA-PACIFIC CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 37. BRAZIL CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 38. SAUDI ARABIA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 39. SOUTH AFRICA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 40. REST OF LAMEA CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET, 2022-2032 ($MILLION)

FIGURE 41. TOP WINNING STRATEGIES, BY YEAR

FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 45. COMPETITIVE DASHBOARD

FIGURE 46. COMPETITIVE HEATMAP: CEMENTLESS TOTAL KNEE ARTHROPLASTY MARKET

FIGURE 47. TOP PLAYER POSITIONING, 2022

FIGURE 48. ZIMMER BIOMET HOLDING INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 49. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 50. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 51. STRYKER CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 52. STRYKER CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 53. STRYKER CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 54. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)

FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)

FIGURE 58. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 59. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 60. MICROPORT SCIENTIFIC CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 61. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 62. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 63. SMITH & NEPHEW PLC: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 64. SMITH & NEPHEW PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 65. SMITH & NEPHEW PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 66. OLYMPUS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 67. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%